Clinical Trial Update: A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating apatinib in patients with locally progressive or metastatic refractory thyroid cancer; the trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Refractory Cancer | Phase 2 | Status: UNKNOWN